Oncology

Latest News

Tech Updates: McKesson Launches Precision Oncology Consortium; Financing for RISA Labs PA Platform

By Mary Caffrey

April 17th 2025

These advances are designed to improve uptake of biomarker-driven cancer care and reduce treatment delays.

Making Novel Cancer Therapies Available Requires Choices Because Resources Are Limited

By Kyle Munz

April 14th 2025

Businessman shows medical network wooden block for health, medicine, insurance, healthcare, care, concept. Medical technology services to solve public - ภัทรชัย รัตนชัยวงค์ - stock.adobe.com.jpeg

NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer

By Giuliana Grossi

April 9th 2025

Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

By Galen Shearn-Nance, BS
Rishi R. Sachdev, BS

April 4th 2025

Woman with keloid on shoulder | Image credit: weerajata – stock.adobe.com

Deep Learning Tool Differentiates Keloids From Malignant Lesions Without Dermoscopy

By Hayden E. Klein

April 2nd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

March 23rd 2017

FDA Approves First Treatment for Rare Skin Cancer, Merkel Cell Carcinoma

AJMC Staff

The first treatment for Merkel cell carcinoma, a rare form of skin cancer, has been approved to treat adults and pediatric patients 12 years or older. The drug is also under consideration through Priority Review for treatment of patients with urothelial carcinoma.

March 23rd 2017

Addressing the Roots of Disparities in Cancer Care: Inherent Bias, Resources, and Insurance

Surabhi Dangi-Garimella, PhD

At the 22nd Annual Conference of the National Comprehensive Cancer Network, held March 23-25, 2017, in Orlando, FL, policy researchers with interest in cancer care disparities discussed the source of existing disparities and how they can be successfully addressed.

March 22nd 2017

ASCO's State of Cancer Care in America Report Addresses Access and Affordability Challenges

Surabhi Dangi-Garimella, PhD

The report, which provides an update on all the monumental changes witnessed by the field of oncology over the last year, highlights 3 key achievements: new investments in science and insurance coverage, payment models that emphasize quality, and rapid-learning healthcare systems.

March 22nd 2017

Immunotherapy 2.0: Dr Patricia Salber Interviews Dr Harold Burstein

The field of immunotherapy is a work in progress and researchers are now expanding the use of this treatment and doing a better job of identifying the patients that will benefit the most from it.

March 22nd 2017

Eliminating Cost Sharing Could Improve Access to Cancer Care, Says Samantha Watson

If the burden of cost sharing no longer fell on cancer patients, they would be more likely to access care and maintain treatment as prescribed, leading to improved outcomes, according to Samantha Watson, founder and CEO of The Samfund. When faced with high copays, patients are more likely to skip appointments or take only half of their prescribed medications.

March 21st 2017

The Slow Adoption of Precision Radiation Therapy in Prostate Cancer

Surabhi Dangi-Garimella, PhD

Do newer forms of radiation treatments surpass standard radiation in prostate cancer?

March 20th 2017

Biomarker Testing Detects Lung Cancer Recurrence 6 Months Prior to CT Imaging

Christina Mattina

According to a new clinical trial, circulating tumor cells can serve as a biomarker that alerts clinicians to the recurrence of non-small cell lung cancer months before it is detected by CT scans.

March 20th 2017

David Fabrizio Discusses Challenges of Biomarker-Driven Cancer Treatment

The use of biomarkers in immunotherapy has some technical and biological limitations, and is complicated further by the qualitative aspect of cancer treatment, said David Fabrizio, of Foundation Medicine, Inc. A genomic-based solution could help develop more unified quantitative approaches.

March 18th 2017

Debra Madden Suggests Oncologists Take a Patient-Centered Approach to Education

Oncology physicians and nurses need to listen to their patients’ needs and expectations to determine the right way to present information on cancer treatments, including immuno-oncology, according to Debra L. Madden, cancer research advocate and patient representative.

March 17th 2017

5 Things to Look for at NCCN's Annual Conference

Surabhi Dangi-Garimella, PhD

A preview of some of the discussions at the 22nd Annual Conference of the National Comprehensive Cancer Network (NCCN).

March 17th 2017

This Week in Managed Care: March 17, 2017

This week, the top managed care stories included the Congressional Budget Office releasing its rating of the GOP's health plan, the Senate voted to confirm Seema Verma for CMS administrator, and Scott Gottlieb, MD, was nominated to lead the FDA.

March 16th 2017

NIH Could See a $6 Billion Funding Cut With New White House Budget

Surabhi Dangi-Garimella, PhD

The White House budget “blueprint” for 2018, which was released today, has recommended substantial cuts to the National Institutes of Health (NIH).

March 16th 2017

Education Can Alleviate Palliative Care Fears Among Patients With Cancer

Christina Mattina

A new study has found that an educational program can help ease worries associated with palliative care, and make cancer patients more likely to use it if referred.

March 15th 2017

Pembrolizumab Approved for Relapsed/Refractory Adult and Pediatric Hodgkin Lymphoma

AJMC Staff

Pembrolizumab (Keytruda) received an accelerated approval for adult and pediatric patients with refractory classical Hodgkin lymphoma or those who have relapsed after at least 3 lines of therapy.

March 15th 2017

Cancer Research Support Linked to Fewer Early Deaths, Hospitalizations

Christina Mattina

A new economic study has found that cancer types that were the focus of articles receiving public or private research support had fewer hospitalizations and lower mortality.

March 15th 2017

Syapse Looks to Expand Precision Medicine Partnerships With New CEO

Surabhi Dangi-Garimella, PhD

Ken Tarkoff, formerly at RelayHealth, is joining Syapse as its new CEO.

March 14th 2017

More Women With BRCA Mutations May Respond to PARP Inhibitors Than Previously Thought

Surabhi Dangi-Garimella, PhD

New research published in Nature Medicine has identified a broader population of individuals with breast cancer who can have therapeutic sensitivity to PARP inhibitors.

March 13th 2017

Ribociclib Approved as Front-Line Therapy for HR+/HER2- Breast Cancer

Laura Joszt, MA

The FDA has approved Novartis’ ribociclib (Kisqali) for treatment of postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer.

March 13th 2017

Changes in Breast Density Following Hormone Therapy Predicts Cancer Risk

Surabhi Dangi-Garimella, PhD

A new study, published in the Journal of the National Cancer Institute, has confirmed that mammographic density change following estrogen and progestin treatment increases the risk of breast cancer.

March 13th 2017

Oncology Medical Homes, Patient Navigators Improved Quality and Saved Costs at End of Life

Christina Mattina

A recent study in Health Affairs assessed cost and utilization outcomes for 3 innovative care models for Medicare beneficiaries with cancer: oncology medical homes, patient navigator programs, and palliative care initiatives.

March 13th 2017

Dr Karen van Caulil Discusses Employers' Concerns About Rising Cancer Costs

The cost of oncology care has increased significantly in recent years, leading employers to worry about how they can provide consistent benefits for employees with cancer and their family members, according to Karen van Caulil, PhD, president and CEO of the Florida Health Care Coalition.

March 11th 2017

Dr Carrie Stricker Explains How Her Clinical Experience Shapes Carevive's Work

Years of experience as an oncology nurse practitioner have underscored the importance of evidence-based resources for both patients and clinicians, says Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.

March 11th 2017

Dr Stuart Goldberg: Patient Input and Data Analysis Are Keys to Value in Oncology

When discussing value in oncology, the outcomes that matter are those that are important to the patient, said Stuart Goldberg, MD, chief medical officer, Cancer Outcomes Tracking and Analysis, John Theurer Cancer Center. He also discussed how the use of data to stratify patients is important for providing value-based cancer care.

March 10th 2017

Imatinib Safe and Effective on Long-Term Use in CML

Surabhi Dangi-Garimella, PhD

The selective BCR-ABL1 kinase inhibitor imatinib mesylate (Gleevec) has been found to be safe and effective following almost 11 years of follow-up in patients with chronic myeloid leukemia.

March 10th 2017

This Week in Managed Care: March 10, 2017

This week, the top managed care news included a bill from House Republicans to repeal and replace the Affordable Care Act, a new program at Walgreens to train pharmacists on an advanced cancer-care curriculum, and findings that health coaching helps the neediest patients most.

March 10th 2017

Patients Who Refuse Intervention for Thyroid Cancer at Risk of Disengaging From Care

Surabhi Dangi-Garimella, PhD

A study evaluating patients diagnosed with thyroid cancer who refused a clinical intervention for fear of being overdiagnosed has reported that the individuals feel isolated and anxious.

March 9th 2017

Slow Cancer Trial Accrual Rates Prevent Clinical Translation of Goals

Surabhi Dangi-Garimella, PhD

A new study from the MD Anderson Cancer Center has identified factors that influence cancer clinical trial accrual rates.

March 8th 2017

Exercise and Psychological Interventions Most Effective for Cancer-Related Fatigue

Christina Mattina

A review of research on the effectiveness of several treatments for cancer-related fatigue determined that exercise and psychological interventions resulted in more significant improvements than pharmaceutical regimens.

March 8th 2017

A Self-Persuasion App to Boost Adolescent HPV Vaccination Among Low-Income Families

Surabhi Dangi-Garimella, PhD

A pilot study conducted at a safety net hospital has armed researchers with a new educational tool: a digital app to persuade parents to vaccinate their adolescent against the human papilloma virus (HPV).

March 7th 2017

Study Compares Cost-Effectiveness of Immune Checkpoint Inhibitors in Advanced Melanoma

AJMC Staff

First-line pembrolizumab every 3 weeks followed by second-line ipilimumab, and first-line nivolumab followed by second-line ipilimumab are cost-effective strategies in patients with advanced melanoma expressing wild-type BRAF.

...

77 78 79 80 81 82 83 84 85

...

184 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions